-+ 0.00%
-+ 0.00%
-+ 0.00%

Voyager Therapeutics’ Amy Quinlan, principal accounting officer, files initial beneficial ownership statement

PUBT·05/18/2026 20:02:00
Listen to the news
Voyager Therapeutics’ Amy Quinlan, principal accounting officer, files initial beneficial ownership statement
  • Voyager Therapeutics Principal Accounting Officer Amy Quinlan filed an initial ownership statement reporting 36,749 shares of common stock.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Voyager Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-063176), on May 18, 2026, and is solely responsible for the information contained therein.